C.D.C. (Europe)

The European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) Regional Office for Europe today published the joint report ‘Tuberculosis Surveillance and Monitoring in Europe 2026’

The European Centre for Disease Prevention and Control (ECDC) assesses the risk to the general population in the European Union and European Economic Area (EU/EEA) of invasive meningococcal disease (IMD) related to the outbreak in Kent, England, as very low due to the very small probability of exposure and infection.

As of March 2026, over 1 000 confirmed and possible cases of shigellosis and other gastrointestinal infections, including salmonellosis, have been detected in travellers returning from Cabo Verde to several countries in the European Union/European Economic Area (EU/EEA), the United Kingdom (UK), and the United States (US), with new cases still being reported.

As of March 2026, over 1 000 confirmed and possible cases of shigellosis and other gastrointestinal infections, including salmonellosis, have been detected in travellers returning from Cabo Verde to several countries in the European Union/European Economic Area (EU/EEA), the United Kingdom (UK), and the United States (US), with new cases still being reported.

The European Commission has issued four new calls for applications for the designation of EU Reference Laboratories (EURLs) for public health.

Today, the European Centre for Disease Prevention and Control, ECDC, and the Africa Centres for Disease Control and Prevention, Africa CDC, signed their first Memorandum of Understanding to strengthen health security in Africa and Europe.

ECDC has launched a call for experts to join a new Scientific Expert Panel (SEP) to support the development of an EU/EEA technical guidance on respiratory syncytial virus (RSV) vaccination to protect adults.

Since November 2025, more than 70 travel-related cases among travellers returning from Seychelles have been reported by 10 European countries.

ECDC is recommending the establishment of four new EU Reference Laboratories (EURLs) for public health.

ECDC and EFSA have published a Rapid Outbreak Assessment (ROA) following the ongoing recall of infant formula products due to the detection of cereulide. The assessment concludes that due to the recall, the current likelihood of exposure to contaminated formula is low.

From 19 December 2025 to 13 February 2026, six EU countries and the United Kingdom reported infants with gastrointestinal symptoms following the consumption of contaminated infant formula.

AMR in common foodborne bacteria such as Salmonella and Campylobacter continues to be a public health concern across Europe, according to a new joint report from EFSA and ECDC.

The European Centre for Disease Prevention and Control (ECDC) and its Director, Pamela Rendi-Wagner, welcomed the President of the Public Health Agency of Canada (PHAC), Nancy Hamzawi, to ECDC on Monday, 16 February 2026.

Preliminary data for 2025 show a significant drop in the number of reported measles cases across European Union and European Economic Area (EU/EEA) countries compared with 2024.

The Winter Olympics will kick off on 6 February 2026 and run until 22 February, while the Paralympics will take place between 6 and 15 March.

On 26 January 2025, the European Centre for Disease Prevention and Control (ECDC) supported the organisation of a simulation exercise (SIMEX) in Malta, to strengthen national preparedness and response to infectious disease outbreaks.

ECDC, Africa CDC and the WHO Regional Office for Africa are conducting training in R programming and epidemic intelligence for surveillance experts from the National Public Health Agency of Sierra Leone.